Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Biote Corp
BTMD
$44.9M
| $1.92M | ﹤0.01% |
575,364
+16,551
| +3% | +$78.9K |
|
3052
OR Royalties Inc
OR
$6.2B
| $1.92M | ﹤0.01% |
89,808
+6,362
| +8% | +$122K |
|
3053
Atossa Therapeutics
ATOS
$23.5M
| $1.92M | ﹤0.01% |
189,719
+2,107
| +1% | +$25.6K |
|
3054
Fennec Pharmaceuticals
FENC
$402M
| $1.9M | ﹤0.01% |
311,332
+8,242
| +3% | +$52.9K |
|
3055
Tango Therapeutics
TNGX
$4.41B
| $1.9M | ﹤0.01% |
1,383,437
-3,012
| -0.2% | -$7.4K |
|
3056
Barnes & Noble Education
BNED
$443M
| $1.89M | ﹤0.01% |
180,173
+23,366
| +15% | +$241K |
|
|
CKPT
3057
DELISTED
Checkpoint Therapeutics
CKPT
| $1.89M | ﹤0.01% |
467,870
+22,759
| +5% | +$75.9K |
|
|
HSHP
3058
Himalaya Shipping
HSHP
$748M
| $1.89M | ﹤0.01% |
344,522
-2,008
| -0.6% | -$10.5K |
|
3059
Corvus Pharmaceuticals
CRVS
$1.17B
| $1.88M | ﹤0.01% |
590,286
+23,423
| +4% | +$110K |
|
3060
Caribou Biosciences
CRBU
$164M
| $1.88M | ﹤0.01% |
2,053,929
+81,534
| +4% | +$106K |
|
3061
Rekor Systems
REKR
$91.7M
| $1.87M | ﹤0.01% |
2,108,627
+166,003
| +9% | +$262K |
|
3062
Silicon Motion
SIMO
$8.68B
| $1.86M | ﹤0.01% |
36,844
+596
| +2% | +$32.2K |
|
3063
Star Bulk Carriers
SBLK
$3.22B
| $1.86M | ﹤0.01% |
119,367
-442,346
| -79% | -$6.9M |
|
3064
MacroGenics
MGNX
$257M
| $1.85M | ﹤0.01% |
1,456,188
+22,971
| +2% | +$60K |
|
3065
Oportun Financial
OPRT
$372M
| $1.84M | ﹤0.01% |
335,452
+18,402
| +6% | +$101K |
|
3066
Melco Resorts & Entertainment
MLCO
$2.14B
| $1.84M | ﹤0.01% |
349,326
-14,764
| -4% | -$83.1K |
|
|
SERV
3067
Serve Robotics
SERV
$433M
| $1.83M | ﹤0.01% |
318,307
+139,527
| +78% | +$1.83M |
|
3068
Smith Douglas Homes
SDHC
$116M
| $1.83M | ﹤0.01% |
93,695
+3,657
| +4% | +$82.2K |
|
3069
Kingstone Companies
KINS
$276M
| $1.83M | ﹤0.01% |
109,818
+6,607
| +6% | +$106K |
|
3070
Full Truck Alliance
YMM
$9.99B
| $1.83M | ﹤0.01% |
143,179
+5,548
| +4% | +$66.9K |
|
3071
Fresenius Medical Care
FMS
$12.9B
| $1.83M | ﹤0.01% |
73,378
-17,372
| -19% | -$414K |
|
3072
Pliant Therapeutics
PLRX
$65M
| $1.83M | ﹤0.01% |
1,353,043
+36,395
| +3% | +$221K |
|
3073
NET Power
NPWR
$134M
| $1.82M | ﹤0.01% |
692,753
+34,190
| +5% | +$241K |
|
3074
Eldorado Gold
EGO
$9.89B
| $1.82M | ﹤0.01% |
106,985
+7,423
| +7% | +$111K |
|
3075
Lifezone Metals
LZM
$370M
| $1.81M | ﹤0.01% |
433,536
-5,005
| -1% | -$28K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.